Author:
Prinz Vavricka Bettina M.,Guitart Joan
Reference98 articles.
1. Ackerman AB (1997) Psoriasis. In: Ackerman AB (ed) Histologic diagnosis of inflammatory skin diseases. An algorithmic method based on pattern analysis. Lippincott Williams and Wilkins, Baltimore, pp 663–673
2. Ackermann L, Harvima IT, Pelkonen J, RitamakiSalo V, Naukkarinen A, Harvima RJ, Horsmanheimo M (1999) Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 140: 624–633
3. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113: 752–759
4. Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, Rosbotham JL, Little AM, Madrigal A, Barker JN, Powis SH, Trembath RC (1999) Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 113: 322–328
5. Barker JN (2001) Genetic aspects of psoriasis. Clin Exp Dermatol 26: 321–325